Liberate Medical

The PREVENT study is the pivotal clinical trial of the VentFree Respiratory Muscle Stimulator and will support FDA regulatory clearance. Liberate Medical announced that patient enrollment in the trial began.

First-in-Class Non-Invasive Ventilator Weaning Technology Fully Enrolled in Global Randomized Controlled Trial; Public Results Presentation Planned for late 2026 CRESTWOOD, KY, March 3, 2026 — Liberate Medical, a clinical-stage medical device company developing breakthrough neuromuscular electric

Second trial to demonstrate improved outcomes in mechanically ventilated patients CRESTWOOD, KY, 16th November 2020 – Applying non-invasive electrical stimulation to the expiratory abdominal muscles may reduce abdominal muscle atrophy and markedly reduce the number of days adult patients

Series B Co-Led by a Large Strategic Investor and Scientific Health Development to Support the Pivotal Clinical Trial of the VentFree Respiratory Muscle Stimulator

Liberate Medical is developing a medical device for mechanically ventilated patients.

Dr. McLachlan co-founded Liberate Medical and has served as its CEO and a board member since 2013. He led initial product development of VentFree and SecondBreath and served as Director for Device Integration and Strategy at Revon Systems from 2014 to 2016.

Cedric Francois specializes in immunology and immune system-mediated disease. He has a medical degree from the University of Leuven and a Ph.D. in Physiology from the University of Louisville, and was part of the research team that performed the first successful hand transplantation.

Christopher DiMatteo has over 20 years of experience in the medical device industry and has managed clinical trials in hospitals, contract research organizations, and medical device manufacturers.

Guillermo J. Cohen Freue has served as Liberate Medical’s Vice President of Engineering since 2016. He previously directed research and development at Angelini Pharma Inc. and has co-founded medical device companies and led teams through FDA clearance processes.

The company has a team that assists with inquiries.

Liberate Medical develops neuromuscular electrical stimulation technology. Its VentFree Respiratory Muscle Stimulator is designed to contract and exercise abdominal muscles to reduce atrophy and the time patients need mechanical ventilation.